Peptides and retinol can be present in the same cosmetic formula; in published studies, products containing both types of ingredients were evaluated. However, the mere fact that such formulations exist does not mean that every peptide is compatible with every product containing retinol. It also does not mean that two separately formulated cosmetics can be mixed together without restrictions, nor that adding a peptide automatically increases the effectiveness of retinol or reduces the risk of irritation.
The word „compatibility” can have several different meanings in cosmetology. The formulation may remain physically stable without stratification or a change in consistency, while a separate analysis is required to determine whether the active ingredients contained in it remain chemically unchanged. The next question concerns whether the ingredients reach the appropriate part of the skin in a biologically relevant form. Another issue is tolerance, which is the way the skin reacts during actual use of the product.
Physical stability, chemical stability, the delivery of ingredients to the skin, and tolerance are all related to each other, but they do not mean the same thing.
Therefore, neither a well-designed list of ingredients nor an attractive „before and after” photo allow for confirmation of all aspects of compatibility. The most valuable evidence relates to the precise formulation, specific ingredients, the conditions under which they were tested, the population studied, and the measured result.
In this article, we look at what research on peptides and retinoids actually shows, where the unknowns still remain, and why results regarding a single product should not be automatically translated into universal rules regarding mixing, layering, or the use of all products containing peptides and retinol.
What are the differences between peptides and retinoids?
Retinol belongs to the vitamin A family
Retinol is a compound belonging to the vitamin A family and to a broader group of substances known as retinoids.
This family also includes retinaldehyde, retinoic acid, numerous retinyl esters, and other derivatives. Although these compounds are chemically related, their names should not be used interchangeably, as they differ in molecular structure, formulation methods, skin metabolism, and biological properties.
Retinol, for example, is not the same compound as tretinoin, which is retinoic acid. It is also different from retinyl propionate, which belongs to the group of retinyl esters.
Therefore, the results obtained for one retinoid should not be automatically presented as evidence regarding another.
This distinction becomes particularly important when the results of scientific research are simplified for the purposes of consumer content regarding skincare. A clinical study involving a skincare regimen containing retinyl propionate cannot be presented as evidence that every product containing retinol will behave in the same way. Similarly, data regarding tretinoin should be described as data regarding tretinoin, rather than the entire category of retinoids.
In a randomized, controlled study involving 36 elderly participants, retinol was applied to the skin of the arm for 24 weeks. Researchers noted improvements in fine wrinkles and changes in selected parameters evaluated in biopsies. [1]
This is valuable evidence regarding the formulation of the retinoid under study, but its interpretation remains limited to the specific population, the application site, the formulation, and the experimental conditions. The study does not show how each serum containing retinoid applied to the face would behave, nor whether adding a peptide would enhance the observed effect.
Peptides constitute a very diverse group of compounds
The term „peptide” describes molecules composed of amino acid residues linked by peptide bonds. However, this broad definition encompasses a vast group of substances with different chemical and biological properties.
In cosmetics, this term can refer to an exactly defined synthetic peptide sequence, a chemically modified peptide, a peptide combined with a lipid group, or a protein hydrolysate containing a mixture of different peptide fragments.
These materials should not be considered equivalent simply because the word „peptide” appears on the label or in the marketing description.
For example, the specifically named acetylated hexapeptide is a specific molecular component and is fundamentally different from the unspecific pea peptide hydrolysate containing a mixture of fragments.
Even among precisely defined chemically defined peptides, relatively small structural differences can affect solubility, stability, interaction with the formulation matrix, and biological activity. Changing the amino acid sequence, adding a lipid group, or introducing other chemical modifications can significantly alter the properties of the resulting component.
From a scientific point of view, it is therefore much more important what exactly the peptide is in the product, than the number of peptides listed on the label itself.
Laboratory studies can verify whether a specific peptide affects cellular signaling, extracellular matrix markers, gene expression, or other biological processes. Such experiments can provide valuable mechanistic information.
However, direct exposure of cells to the peptide under laboratory conditions does not prove that the finished cosmetic product applied topically will deliver the same peptide through the intact skin barrier to these cells and provide comparable exposure.
Peptides identified or studied using laboratory methods can also be evaluated using techniques such as phage display. However, this is a stage of molecular research, not proof of the efficacy of a finished cosmetic on the skin. For more information on how peptide candidates are selected and validated, see the article Phage display of peptides.
Different mechanisms of action do not automatically lead to synergy
The study of components acting through different biological or formulation mechanisms can be scientifically justified. However, the mechanistic reliability itself should not be automatically considered synergy.
Synergy is a much stronger claim than the mere coexistence of components or their complementary action.
In scientific terms, it means that the effect obtained through the combination of components is greater than the clearly specified expected effect resulting from the action of the individual components.
Demonstrating such an interaction requires a properly designed study that allows for a proper comparison of the individual components.
If researchers assess only the finished serum containing the peptide and the retinoid before starting use and after a few weeks, the improvement compared to the initial value does not prove that the peptide itself increased the effect of the retinoid.
The observed result may result from the action of the retinoid, the peptide, the moisturizing base of the formulation, another component, or the combined effect of several components without the occurrence of a real synergy.
A 2025 study comparing serum containing cyclized peptide with serum containing retinol and the base of the formulation clearly shows this difference.[2]
The study evaluated the comparative effects of different preparations. The combination of the peptide with retinol was not analyzed. Additionally, the comparator preparation containing retinol had a specific, low concentration.
These results should therefore not be interpreted as evidence that peptides as a whole category perform better than all retinol products, nor that both components must work more effectively when combined.
Peptides and retinol in one formula and the use of two separate products
The product that combines both ingredients is a deliberately designed system
When a manufacturer develops a cosmetic containing both a retinoid and peptide ingredients, a deliberately designed formulation is created, rather than a random mixture of ingredients.
During its development, the substrate, emulsifying system, concentration of ingredients, packaging, production process, antioxidant system, and other parameters can be selected, taking into account the properties of the individual substances.
The finished product can then be subjected to tests for physical, chemical, and tolerance stability under specific conditions.
A 2023 study evaluated a cream containing retinol, a tripeptide concentrate, and glaucine in 20 participants for approximately three months. During the study, clinical and histological changes were observed.[3]
The study shows that the formulation containing these ingredients has been prepared and clinically evaluated.
However, the small number of participants, the open nature of the study, and the presence of several active ingredients make it impossible to identify a specific role of the peptide in the observed effect.
The results also do not prove that every cream containing a similar list of ingredients will behave in the same way.
The mere existence of a product on the market that combines these ingredients should therefore be considered as the beginning of the question of formulation, and not as independent evidence that all the ingredients remain compatible throughout the entire declared shelf life period.
It would be ideal if the compatibility data referred to the actual formulation and its stability under the appropriate storage conditions.
The general principles regarding why stability depends on the specific material, formulation, packaging, and environmental conditions are described in more detail in the article. Storage of peptides.
Layering two products is another situation
Applying two independently developed products one after the other is not the same as using a single cosmetic product in which the ingredients were intentionally combined during the formulation process.
Each product has its own base, concentration of ingredients, pH, membrane-forming properties, delivery system, and instructions for use.
Sequential application therefore creates different exposure conditions than the ready-made, previously tested mixture.
One cosmetic can change the environment on the surface of the skin created by another. It can affect drying, distribution, occlusion, or a layer remaining on the skin.
It is not possible to reliably predict solely on the basis of the words „peptide” and „retinol” whether these changes will have a significant impact on the delivery of the ingredients, their stability, or their tolerance.
The studies examined here do not indicate a scientifically validated sequence of applications that would be appropriate for each peptide serum and each retinol cream.
The popular rule of applying cosmetics from the lightest to the heaviest consistency can be a convenient element of daily skincare, but it does not prove that this order increases the penetration of a peptide or the effectiveness of retinol.
The most important information remains therefore the information regarding specific products, data on the actually tested combination — if available — and the observed tolerance.
A specific care regimen should not be presented as experimentally validated unless such a regimen has been tested.
Mixing two ready-made products changes the system under study
The physical combination of two ready-made cosmetics before application creates an even more complex situation.
If the two formulations are mixed together in the hand or transferred to a common container, the relative concentrations of the components and their immediate formulation environment change.
The data regarding the stability, maintenance and compatibility of each of the original products may therefore no longer describe the properties of the newly created mixture.
This does not mean that every such connection must immediately degrade or become unstable.
However, it means that the evidence regarding the two original products cannot automatically confirm the chemical and physical properties of the newly formed mixture.
A clinical study of a professionally formulated cosmetic product containing a peptide and a retinoid allows conclusions to be drawn about this specific, tested formulation. It does not constitute a scientific recipe that allows it to be reproduced by mixing two independent products available on the market.
Similarly, the peptide raw material intended for professional formulations is fundamentally different from a finished cosmetic product.
The technical documentation of the raw material should not be interpreted as instructions for adding it to an already prepared cosmetic product.
Using it during one routine and chemical stability are two different questions
Chemical stability should also be distinguished from the tolerance of products used during the same care routine.
Chemical stability answers the question of whether specific molecules remain chemically unchanged under the conditions of formulation and storage.
Tolerance refers to how the skin reacts to a specific product or combination of products used according to a specific regimen.
The formulation can remain chemically stable while still causing irritation in some people.
On the other hand, a product may be well tolerated during use, but this observation alone does not prove that all of its active ingredients remain chemically unchanged throughout the entire shelf life.
Different experimental methods therefore answer different questions.
A chromatogram can provide information about the chemical composition. A skin test can provide information about a specific type of skin reaction. A photo of wrinkles can document the appearance of the skin under specific conditions.
None of these measurements can automatically replace the others.
Formulation, stability and irritation
The content of the retinoid can change during storage
Retinoids can undergo degradation, and their range is strongly dependent on the formulation and environmental conditions.
One study analyzed 12 commercially available cosmetic products using a validated chromatographic method. During the stability studies, significant differences were observed depending on the formulation. Exposure to light also affected the retinoids under study [4].
The results relate to specific products and experimental conditions and should not be interpreted as evidence of identical instability in all currently available retinoid-containing cosmetics.
The study shows an important principle, however: the mere presence of a component on the label does not tell us how much of it will remain in the product at the end of the declared shelf life.
The packaging, exposure to light and air, the chemistry of the entire formulation, storage conditions, and the results of appropriate analyses can all be important factors.
A cosmetic product can also appear unchanged despite changes occurring in its chemical composition.
The absence of visible discoloration, stratification, or change in consistency does not indicate the retention of the initial concentration of the retinoid.
Physical appearance and chemical composition are separate properties and require different assessment methods.
Carrier systems can be studied without demonstrating clinical superiority
Encapsulation consists of placing a component in a specific delivery structure instead of leaving it in the same physical form as the unencapsulated component.
Researchers analyzing encapsulated cosmetic ingredients can measure, among other things, particle size, their size distribution, surface charge, the degree of loading of the ingredient, the characteristics of release, and chemical behavior during storage.
These measurements can provide valuable information about the formulation system, but they do not automatically lead to better clinical outcomes.
In a 2024 study, stable lipid nanoparticles containing retinol and pentapeptide-18 were developed and their physicochemical properties were monitored for approximately four weeks.[5]
The study supports the possibility of applying the formulated approach under certain experimental conditions.
However, maintaining particle size properties does not in itself prove the long-term chemical stability of each encapsulated component, increased delivery to the skin, reduced irritation, or a better effect on wrinkles in humans.
The term „encapsulated” should therefore lead to a more specific question: what property has improved, compared with what, under what conditions, and using which method was it measured?
Encapsulation is a formulation technology. In itself, it does not guarantee greater penetration, better tolerance, or better clinical effects.
Irritation depends on the entire product and the method of exposure
Many factors can affect skin irritation: the retinoid itself, its concentration and delivery system, the formulation base, other ingredients, the method of application, the skin condition, and other products used at the same time.
The addition of the peptide does not automatically neutralize all of these factors.
In an eight-week study, the essence containing encapsulated retinol and acetyl-hexapeptide-1 was evaluated in 32 middle-aged Chinese people. The researchers noted an improvement in the analyzed parameters and acceptable tolerability under the study conditions. A comparison was also performed using a plate-based test for the encapsulated material.[6]
The results provide information regarding the specific formulation and the selected study population.
They do not indicate a universal concentration, frequency of use, or peptide-retinol combination regimen appropriate for each individual.
Similarly, the absence of significant irritation in a small study does not mean that more rare reactions are impossible.
The interpretation of tolerance is more reliable when the study clearly specifies the participants, the evaluated responses, the way adverse events are defined, and information about any discontinuation of participation in the study.
pH is only one of the components of a formulation
pH often appears in online discussions regarding the compatibility of cosmetic ingredients, but it is only one element of a much more complex formulation system.
The pH of a product can affect the surrounding environment of water-soluble ingredients and the conditions on the skin's surface. However, the pH value alone does not determine whether the two ingredients are chemically compatible.
Individual peptides may differ in their sensitivity to chemical changes, whereas retinoids may be present in different phases of emulsions or in different delivery systems.
Therefore, two products with similar declared pH values do not necessarily have the same stability, nutrient delivery capacity, or tolerance.
The reverse situation is also important.
The difference between the declared pH of two cosmetics does not prove that their ingredients immediately destroy each other when used as part of a routine.
A scientifically justified claim regarding compatibility should indicate the specific components, formulation, study conditions, and parameter being evaluated.
Universal statements referring to all peptides and all retinoids go beyond what such data can confirm.
How should evidence regarding combined products be evaluated?
First, it is necessary to determine which question the given survey answers.
Different research projects provide different types of information.
Distinguishing them helps to avoid situations where laboratory results, formulational measurements, and clinical observations are presented as if they confirm exactly the same thing.
| Type of study | What it can show | What still remains unresolved |
|---|---|---|
| Cellular experiment | The biological response during controlled, direct exposure | Delivery through intact human skin and visible effects |
| Study of formulations | Selected parameters of stability, release or delivery | Clinical efficacy, if not separately tested |
| Uncontrolled study before and after | Changes observed during use of the product | Was the change due to the product, one component or another factor? |
| Controlled study under controlled conditions | Additional effect of the formulated product compared to its base | The contribution of the individual active ingredients without further comparisons |
| Comparison of complete schematics | Relative results obtained for the tested schemes | Which specific component is responsible for the difference |
| Factorial or component-controlled study | The role of individual components and possible interactions in the studied system | Possibilities of generalization to other formulations, concentrations, and populations |
Before interpreting the results, it is therefore necessary first to define the category of evidence.
Statistically significant change in the cellular marker is not the same as a visible improvement in wrinkles on the face.
Similarly, an improvement in the instrumental measurement of moisture does not automatically indicate a remodeling of collagen in the epidermis.
The scheme with retinyl propionate is not a single experiment regarding retinol and peptide.
In a randomized study from 2010 involving 196 women, a multi-product cosmetic regimen containing niacinamide, peptides, and retinyl propionate was compared with a regimen based on tretinoin.
During the first eight weeks of the comparison in the group using the cosmetic regimen, favorable results were noted regarding wrinkles and tolerability, and smaller groups were observed over a longer period of time.[7]
This is a valuable example of evidence related to the entire caregiving scheme, but several variables differed between the groups at the same time.
The study cannot therefore show that the peptides themselves reproduced the effects of tretinoin.
The name retinyl propionate should not be changed to „retinol” during discussion of the results.
Most importantly, another cosmetic containing peptides and retinol cannot be considered equivalent just because it contains ingredients belonging to similar categories.
The correct interpretation should preserve the actual names of the components, the applied schematics, the comparison groups, and the limitations of the original experiment.
More recent studies provide additional data, but they do not solve the problem of attributing the effect.
More recent studies of complex products provide further information, but the fundamental problem of determining the share of individual components remains.
In the 2025 publication, laboratory studies were combined with an eight-week evaluation of 30 participants using a formulation containing retinol, a retinoid ester, a pea peptide, and antioxidants.
Among other things, hydration, transdermal water loss, and skin elasticity were analyzed, with improvements noted compared to baseline values.[8]
These observations justify further research into this particular formulation.
However, since the product contained several components at the same time, the results do not allow for the identification of the contribution of the peptide itself.
The 2026 publication analyzed serum containing retinol, hydroxycinnamate retinoate, peptides, and silibinin using cell models, ex vivo studies, and clinical evidence. [9]
The individual parts of such a study answer different scientific questions.
The molecular interactions observed in the model may support the hypothesis regarding the mechanism of action, but they should not automatically be translated into evidence that the peptides induced a clinically relevant synergy in humans.
This is especially important when the language used in the discussion or conclusions of the publication goes beyond what is necessary to establish the structure of the comparison groups.
It is possible to simultaneously conclude that the given formulation led to a measurable improvement, and to note that the contribution of a specific component to this effect remains unexplained.
The population, the duration of the study, and the type of outcome measured are important factors.
The population studied largely determines how widely the results regarding skin care can be generalized.
A small study involving people with mild signs of photoaging cannot automatically represent all age groups, skin phototypes, dermatological diseases, or people with a history of hypersensitivity.
The results obtained for the face skin do not have to describe the skin of the neck or shoulders. The results regarding a single anatomical area should not be transferred to another without appropriate data.
The duration of the study is equally important.
A few weeks of observation can provide information about short-term effects and tolerability, but it does not allow determining what happens after many years of regular use.
The type of endpoint also matters.
Instrumental moisture measurement can improve without showing lasting changes in the deeper structure of the underlying skin.
The assessment of wrinkles by the researcher may change, but this does not automatically mean that every participant noticed a difference that was significant for them.
Histological results and biopsies constitute another category of evidence and should not be treated as equivalent to visible cosmetic effects.
Sources of funding and the authors' affiliations are also worth analyzing in conjunction with the methodology.
Commercial involvement in itself does not mean that the study is flawed. However, transparent reporting, appropriate control groups, and independent replication of results can increase confidence in the conclusions.
How to read product instructions and declarations?
First, determine what exact ingredients are contained in the product
The first step in interpreting the declaration regarding peptides and retinoids is to determine what exact substances are present in a given product.
In the case of a retinoid, it is necessary to check whether it is retinol, retinyl ester, retinaldehyde or another specifically named retinoid.
In the case of the peptide component, however, it must be determined whether the label identifies a specific peptide sequence, a modified peptide, a concentrate containing peptides, or a broader mixture of hydrolyzed proteins.
The declared percentage values also require context.
The formulation may contain a specific percentage of commercial peptide concentrate, which does not necessarily mean the same percentage concentration of the isolated, pure peptide.
The concentration of the applied raw material and the concentration of the actual peptide molecule do not have to be identical.
Marketing slogans such as „retinol and peptide complex” also require careful interpretation.
This term can describe a mixture of ingredients and does not necessarily mean that retinol and a peptide are chemically linked to each other.
Similarly, evidence regarding a single brand product cannot be transferred to another product simply because both use similar marketing terms.
The brand names appearing in search queries do not constitute categories of scientific evidence.
The important question is: did the study involve the same formulation and the same claimed effect?
The instructions for use refer to a specific formulation
The product instructions describe the intended method of use of a specific formulation.
Depending on the cosmetic product, this may include the application site, storage, use of other products, precautions, and additional issues related to the specific form of the product.
The application scheme used in the scientific study describes an intervention that was actually tested.
It should not be automatically converted into a general recommendation for any other cosmetic product containing ingredients belonging to the same categories.
If the instructions for the two products are contradictory, the general statement regarding peptides and retinol does not resolve this conflict solely based on the names of the ingredients.
Similarly, persistent or significant irritation should not be ignored just because the product contains peptides.
The studies analyzed did not establish a universal waiting time between applications, a sequential order of application, or a rule requiring that each person use the peptides and retinol together.
Such claims would require direct evidence regarding a specific scheme.
„Clinically tested” should be the beginning of the question, not the final argument
The term „clinically reviewed” is much more useful when it is used as the starting point for the analysis of the evidence rather than as the final conclusion.
It is worth asking: what exactly was measured, how many participants took part in the study, who they were, how long they used the product, what the comparison group was, and whether the formulation being tested actually corresponds to the product to which the given claim refers.
The consumer questionnaire, the researcher's assessment, instrumental measurement, and skin biopsy constitute very different types of evidence.
A scientifically cautious statement might therefore read:
„In the formulation under investigation, an improvement in a specific parameter was noted under the conditions of the given study.”.
This is much more precise than the statement:
„Peptides make retinol work better,”,
if the experiment did not separately compare the participation of the peptide.
Frequently asked questions
1. Can one product contain both peptides and retinol at the same time?
Yes. In published studies, formulations containing both peptides and retinoids were evaluated. One example is a cream containing retinol, a tripeptide concentrate, and glaucine, which was evaluated clinically and histologically. [3] This shows that a specific combination can be developed and tested. However, it does not prove universal compatibility of every peptide with every retinol-containing product. Because the study involved a multi-ingredient product, it also does not allow one to independently determine which part of the observed effect resulted from the presence of the peptide.
2. Is there a correct order in which all products should be applied?
No. The available evidence does not indicate a universal order of application for all products containing peptides and retinol. Research on ready-made complex formulations concerns specific systems, not all possible order of application of independently developed cosmetics. The study of encapsulated retinol illustrates well the importance of a specific formulation. [6] The instructions for the product actually used and the data related to a specific regimen are therefore more informative than the universal principle of layering.
3. Are retinol and peptides the same type of ingredients?
No. Retinol is a specific compound belonging to the vitamin A family, whereas peptides are chains of amino acids that encompass many different chemical structures and modifications. Therefore, studies of retinol and experiments concerning specific peptides relate to different substances and different biological questions. [1,2] Neither the word „retinol” nor „peptide” allows us to predict the behavior of all formulations containing that category of ingredients.
4. Is retinyl propionate the same as retinol?
No. Retinyl propionate is a derivative of retinyl and during discussions of the studies it should be identified by its proper chemical name. The schematic depicting retinyl propionate was compared to a schematic based on tretinoin, but this study cannot properly be presented as evidence regarding all retinoid serums. [7] Individual retinoids and formulations require data relating to these specific materials.
5. Do peptides always prevent irritation caused by retinol?
No. The presence of a peptide does not guarantee that a retinoid formulation will not cause irritation. Good tolerability of a single multi-ingredient product in a selected population does not prove that the peptide is responsible for it, nor that every person will react in the same way. In a study involving 30 participants, favorable observations were noted for a specific formulation under specific experimental conditions.[8] Tolerance should therefore be evaluated at the level of the entire product and the studied population.
6. Does encapsulation guarantee better results?
No. Encapsulation describes the formulation development process, not the guaranteed clinical outcome. Nanoparticle studies can demonstrate a specific particle size, loading degree, release characteristics, or short-term physical stability, without simultaneously proving a better reduction in the visibility of wrinkles or other effects in humans. A study of nanoparticles containing retinol and pentapeptide-18 illustrates this difference well.[5] Any claimed benefit from encapsulation should therefore indicate exactly which property has been studied and with what it is compared.
7. Is testing a combined product evidence that two separate cosmetics can be mixed?
No. A professionally formulated complex formulation is not equivalent to mixing the two independent finished products separately. Mixing changes the ratios and the immediate formulation environment, while published evidence remains associated with the preparation that was actually tested. Studies demonstrating the formulation-dependent stability of retinoids further indicate why this distinction is important. [4] Data on the starting products do not establish the stability of the newly formed mixture.
8. Does the improvement in wrinkle assessment indicate an increase in collagen levels?
No. The wrinkle assessment describes the appearance of the skin according to the method used. Claims regarding collagen require separate measurements, and even markers related to collagen assessed in biopsies should not automatically be equated with all aspects of true skin remodeling. In a controlled study of retinol, clinical results and selected tissue parameters were evaluated separately. [1] When interpreting cosmetic studies, these endpoints should also remain separate.
9. Does the cell study prove that the serum works on human skin?
No. Direct exposure of cultured cells to the ingredient does not replicate the skin barrier, metabolism, formulation properties, or delivery conditions found in intact human skin. Studies that combine cell models with clinical part utilize these experiments to answer various questions.[9] The cellular response may support the investigation of a potential mechanism, but by itself does not demonstrate apparent efficacy of the finished serum in humans.
10. What does synergy mean when combining components?
Synergy means that the combination of components produces an effect greater than the clearly defined effect expected based on the action of the individual components. Therefore, demonstrating it requires appropriate comparisons, not just the statement that the mixture resulted in an improvement. Mechanistic studies can analyze the interactions between components without demonstrating that a peptide produced a clinically significant synergy. [9] Therefore, this term should remain associated with a specific experiment and the endpoint at which the given interaction was evaluated.
11. Does a higher number of peptides mean a better product?
No. The number of peptide ingredients listed in the formulation is not a validated measure of cosmetic efficacy. Available studies concern specific peptides or mixtures containing peptides in specific formulations, often together with several other active ingredients. They do not demonstrate a general relationship, according to which increasing the number of peptides leads to increasingly greater benefits. [8] Data regarding a specific formulation are more informative than the length of the peptide list on the label.
12. Can retinol undergo degradation without visible changes in the product?
Yes. The chemical composition and appearance of the product are two different properties. Analytical studies available for cosmetics containing retinoids have shown differences in stability depending on the formulation.[4] Therefore, the product may appear normal even though the retinoid content has changed. Visual assessment does not allow determining the amount of remaining retinoid or identifying all degradation products, therefore claims regarding stability and shelf life require appropriate analytical data.
13. Does a study comparing a peptide with retinol prove that they work better together?
No. The comparison of a peptide product with a product containing retinol does not examine the effect of their combination. In the cyclized peptide study, separate groups were used that received the peptide, retinol, and the formulation base, rather than the group that used the peptide-retinol combination. [2] The results therefore only apply to the interventions that were actually compared. Determining whether adding the peptide improves the efficacy of the formulation containing retinol requires a different study design.
14. Can the results regarding the neck cream be transferred to any face serum?
No. The anatomical region, the type of substrate, the concentrations of ingredients, and the population being studied can all influence the results. The study of a cream containing retinol, tripeptide, and glaucine concerned a specific formulation being evaluated in a small facial and neck study.[3] The results do not demonstrate that a serum formulated independently would behave identically. Generalization requires a reasonable relationship between the studied formulation and the conditions to the product to which the claim is to be applied.
15. Does good tolerance mean that the product is suitable for all types of sensitive skin?
No. The beneficial tolerance in the selected group of volunteers does not mean that the product is suitable for every person or for all dermatological diseases associated with skin hypersensitivity. Short cosmetic studies may exclude individuals with active skin diseases, intense irritation, or a specific history of reactions. The results of the essence study conducted on 32 women should therefore remain limited to the studied population and conditions. [6] Wider claims regarding sensitive skin require appropriately selected participants and a clearly defined tolerance assessment.
16. Does the given percentage always mean the percentage of pure peptide?
No. The percentage value given may refer to a commercial concentrate containing a peptide, and not to the isolated peptide molecule itself. For example, a publication on a cream containing retinol and a tripeptide describes the use of a tripeptide concentrate. [3] Without knowledge of the concentration of the concentrate and the way it is reported as a percentage, this value should not be interpreted as a percentage of pure peptide in the finished cosmetic product. Comparisons are more reliable when the units and the composition of the raw material used are clearly defined.
17. Which study would best show whether adding the peptide actually helps?
A particularly informative project would be one that compares formulations that are as similar as possible, with the main difference being the presence or absence of a peptide, while simultaneously measuring clinically relevant outcomes and tolerability. A factorial design could provide additional information by separately evaluating the individual components and their interactions within the same experiment. Multi-product design studies cannot distinguish the contribution of a peptide if several elements are simultaneously changed. [7] The strength of the claim that a peptide provides an additional benefit therefore depends largely on whether the study design actually allows for the separation of its effect from the other components of the formulation.
Applications
Peptides and retinol can coexist in tested cosmetic formulations, and published studies show that products containing both categories of ingredients can be developed and evaluated.
However, this observation should not be turned into a universal principle that every peptide is compatible with every retinoid, or that any two products containing these ingredients can be mixed or applied in layers without any difference.
What matters most is that compatibility has many dimensions.
The physical stability of the formulation, the chemical behavior of the active ingredients, their delivery to the skin, tolerance, and clinical results are separate questions that require different types of evidence.
A formulation may be suitable in one respect, without automatically meeting all the other criteria.
The exact identity of the ingredients is also important.
Retinol should not be treated as a substance that can be substituted with tretinoin, retinyl propionate or any other retinoid.
Peptides also form an extremely diverse group — from precisely defined synthetic sequences, through modified peptides, to complex hydrolysates.
Data regarding a single molecule should not be automatically transferred to the entire category.
Existing studies on complex products provide valuable information related to specific formulations.
In some studies of products containing retinoids and peptides, beneficial clinical, instrumental, or histological results were observed.
However, many such preparations contain several active ingredients simultaneously, which makes it difficult to determine which part of the observed effect was specifically due to the presence of the peptide.
The same caution is needed when considering claims about synergy.
Different mechanisms of action can provide a rational basis for examining a given connection, but biological plausibility is not the same thing as demonstrated synergy.
Confirmation that the addition of the peptide actually improves the efficacy of formulations containing a retinoid requires an experiment that allows the identification of this effect.
Formulation data should not be turned into universal instructions for use either.
A deliberately designed product containing a peptide and a retinoid is different from sequentially applying two independent products. Both of these situations, in turn, differ from physically mixing the products before application.
Available studies do not establish a scientifically validated sequence of application, a waiting period between applications, or a mixing regimen that would be appropriate for all formulations containing peptides and retinol.
The most justified interpretation therefore remains specific to the product and the available evidence.
Before drawing a conclusion, it is necessary to specify the specific retinoid, peptide, formulation base, population being studied, duration of the experiment, comparison group, and the measured result.
Peptides and retinol can be compatible in appropriately designed formulations, but compatibility, stability, tolerance, and improvement in clinical outcomes should be demonstrated, not assumed.
Disclaimer
This article is purely educational and scientifically informational in nature. It discusses cosmetic ingredients, formulation principles, and published studies regarding skin care. It does not constitute an individual skincare regimen, diagnosis, therapeutic recommendation, or medical advice.
Information regarding peptides, retinol, retinoids, formulation stability, layering, mixing of products, encapsulation, and tolerance should not be interpreted as recommendations for combining specific products or modifying finished cosmetic formulations. Evidence obtained for one formulation does not mean that another formulation containing similarly named ingredients will have the same chemical stability, ingredient delivery characteristics, tolerance, or clinical effects.
Skin reactions may vary depending on the formulation, concentration, method of use, other products used, and individual characteristics. The tolerance results obtained in selected study populations therefore do not prove that a given product or combination of ingredients will be suitable for every person, including those with sensitive skin or a dermatological condition.
If the manufacturer of a cosmetic product provides specific instructions, warnings, or storage conditions, these apply to that specific formulation. In the case of persistent irritation, skin disease, or questions regarding individual use, the appropriate source of information is a qualified physician or dermatologist, not general information about entire categories of ingredients.
References
- Kafi, R., Kwak, H. S., Schumacher, W. E., Cho, S., Hanft, V. N., Hamilton, T. A., King, A. L., Neal, J. D., Varani, J., Fisher, G. J., Voorhees, J. J., & Kang, S. (2007). Improvement of naturally aged skin with vitamin A (retinol). Archives of Dermatology, 143(5), 606–612. https://doi.org/10.1001/archderm.143.5.606
- Chang, H., Tao, K., Yang, Y., Wang, Y., Ge, M., Wang, X., Tang, S., & Yu, H. (2025). Novel cyclized hexapeptide-9 outperforms retinol against skin aging: A randomized, double-blinded, active- and vehicle-controlled clinical trial. Journal of Cosmetic Dermatology, 24(7), Article e70290. https://doi.org/10.1111/jocd.70290
- Rao, S., & Goldberg, D. (2023). Clinical and histologic findings after use of a novel combined retinol, tripeptide, and glaucine-containing cream in the treatment of photo-aged skin. Journal of Cosmetic Dermatology, 22(10), 2765–2768. https://doi.org/10.1111/jocd.15945
- Temova Rakuša, Ž., Škufca, P., Kristl, A., & Roškar, R. (2021). Retinoid stability and degradation kinetics in commercial cosmetic products. Journal of Cosmetic Dermatology, 20(7), 2350–2358. https://doi.org/10.1111/jocd.13852
- Pawłowska, M., Marchek, M., Jankowiak, W., & Nowak, I. (2024). Solid lipid nanoparticles incorporated with retinol and pentapeptide-18—Optimization, characterization, and cosmetic application. International Journal of Molecular Sciences, 25(18), Article 10078. https://doi.org/10.3390/ijms251810078
- Ye, Y., Li, Y., Xu, C., & Wei, X. (2023). Improvement of mild photoaged facial skin in middle-aged Chinese females by a supramolecular retinol plus acetyl hexapeptide-1 containing essence. Skin Health and Disease, 3(4), Article e239. https://doi.org/10.1002/ski2.239
- Fu, J. J., Hillebrand, G. G., Raleigh, P., Li, J., Marmor, M. J., Bertucci, V., Grimes, P. E., Mandy, S. H., Perez, M. I., Weinkle, S. H., & Kaczvinsky, J. R. (2010). A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen. British Journal of Dermatology, 162(3), 647–654. https://doi.org/10.1111/j.1365-2133.2009.09436.x
- Cook, B., Riggs, M., Holley, K. C., Knaggs, H., Diwakar, G., & Lephart, E. D. (2025). Effects of retinol, natural pea peptide, and antioxidant blend in a topical formulation: In vitro and clinical evidence. Dermatology and Therapy, 15(1), 189–200. https://doi.org/10.1007/s13555-024-01332-8
- Shen, Y., Shi, M., Ye, Y., Xu, C., Feng, X., Bi, T., Chen, Y., Huang, J., Li, Y., & Sun, P. (2026). An innovative serum with retinol, hydroxypinacolone retinoate, peptides, and silybin improves mild photoaged facial skin in middle-aged Chinese women. Journal of Cosmetic Dermatology, 25(1), Article e70627. https://doi.org/10.1111/jocd.70627